Michael R Betts

25PUBLICATIONS

194CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|May 08, 2026

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs.

|Dec 25, 2025

Dysregulated lymphocyte localization in idiopathic multicentric Castleman disease.

Melanie D Mumau, Michael V Gonzalez, Katherine S Forsyth

|Oct 14, 2025

Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis.

Annika Niehrs, Laura Hertwig, Marcus Buggert

|Aug 14, 2025

Therapeutic CD8+ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.

M Betina Pampena, Sadia Samer, Elise G Viox

|May 18, 2025

Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset.

Gregory J Golden, Vincent H Wu, Jacob T Hamilton

|Jun 17, 2024

Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence.

Zachary Strongin, Laurence Raymond Marchand, Claire Deleage

Pageof 5

Frequent Collaborators

12 joint publications

Maria Betina Pampena

10 joint publications

Leticia Kuri-Cervantes

9 joint publications

E John Wherry

9 joint publications

Laura Vella

7 joint publications

Sokratis A Apostolidis

Divij Mathew

Marcus Buggert

Derek A Oldridge

Scott E Hensley

Amy E Baxter

Frequent Collaborators

12 joint publications

Maria Betina Pampena

10 joint publications

Leticia Kuri-Cervantes

9 joint publications

E John Wherry

9 joint publications

Laura Vella